Boston Scientific's Growth In Key Businesses Helps In Delivering Solid Q4 Results

Global medical device maker Boston Scientific continued to sustain its momentum and delivered strong fourth quarter results with its sales reaching $1.89 billion, a 7% year-over-year (y-o-y) increase in its operational revenue owing to robust growth in emerging markets. Emerging markets, contributing 10% of total sales, grew at 17% y-o-y in the last quarter.